Assoc. Prof. Ozlem Dogan

Assoc. Prof. Ozlem Dogan
Academic Title :
Assoc. Prof.

Assoc. Prof. Dr. Özlem Doğan is a Medical Oncology specialist practicing at Liv Hospital Bahçeşehir in Istanbul, Turkey. Her officially listed clinical interests include the medical treatment of breast cancer, gynecological cancers, lung cancer, colorectal cancer, and gastric cancer, as well as cancer immunotherapy and individualized systemic treatment planning. She graduated from Karadeniz Technical University Faculty of Medicine in 2013, completed her Internal Medicine residency at Haseki Training and Research Hospital in 2018, and completed her Medical Oncology subspecialty training at Ankara Etlik City Hospital in 2024. Her previous appointments include Suluova State Hospital, Adıyaman University Training and Research Hospital, and Altınbaş University Medical Park Bahçelievler Hospital. She has authored and co-authored peer-reviewed studies on gastric, lung, colorectal, and breast cancers.

Education and Academic Qualifications

  • Doctor of Medicine, Karadeniz Technical University Faculty of Medicine (2006-2013)
  • Residency in Internal Medicine, Haseki Training and Research Hospital (2013-2018)
  • Subspecialty in Medical Oncology, Etlik City Hospital (2020-2024)

Areas of Interest

  • Medical oncology and systemic cancer treatment in Turkey.

  • Medical treatment of breast cancer.

  • Systemic therapy for gynecological cancers, according to cancer type and stage.

  • Medical treatment of lung cancer.

  • Colorectal cancer systemic therapy.

  • Gastric cancer treatment.

  • Cancer immunotherapy.

  • Individualized oncology treatment planning based on tumor characteristics, stage, molecular findings, and patient health status.

  • Internal Medicine Specialist at Suluova State Hospital
  • Medical Oncology Specialist at Adiyaman University Training and Research Hospital
  • Medical Oncology Specialist at Altinbas University Medical Park Bahcelievler Hospital
  • Medical Oncology Specialist at Istinye University Hospital Liv Hospital Bahcesehir
  • Turkish Society of Internal Medicine Specialization
  • Turkish Society of Medical Oncology
  • European Society for Medical Oncology (ESMO)
  • American Society for Clinical Oncology (ASCO)
  • "Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment." Journal of the College of Physicians and Surgeons Pakistan. 2023. Fourth author: Özlem Doğan. DOI: 10.29271/jcpsp.2023.07.770.

  • "Is Hemoglobin, Albumin, Lymphocyte, and Platelet Score a Prognostic Indicator in Metastatic Squamous Cell Lung Cancer?" Acta Haematologica Oncologica Turcica. 2025;58(1):36–39. First author: Özlem Doğan. DOI: 10.4274/ahot.galenos.2025.2024-9-1.

  • "Stage II-III colorectal cancer in geriatric patients: Clinicopathological features and chemotherapy utilization." Turkish Journal of Clinics and Laboratory. 2025;16(1):118–122. Second author: Özlem Doğan. DOI: 10.18663/tjcl.1647734.

  • "Aggressive breast cancer in young women: Single-center experience." Adıyaman Üniversitesi Sağlık Bilimleri Dergisi. 2025;11(1):37–42. First author: Özlem Doğan. DOI: 10.30569/adiyamansaglik.1587581.

  • "Prognostic Value of the Hemoglobin, Albumin, Lymphocyte, Platelet Score in Metastatic Mesothelioma: A Retrospective Study." Oncology. 2026;104(4):440–447. Published online in July 2025. First author: Özlem Doğan. DOI: 10.1159/000547271.

Share :